The value of new high-throughput technologies for diagnosis and prognosis in solid tumors

Rosamaria Pinto, Simona De Summa, Daniela Petriella, Oana Tudoran, Katia Danza, Stefania Tommasi

Research output: Contribution to journalArticle

Abstract

Advances in our understanding of the molecular basis of tumors, as well as in the technology of DNA analysis, are rapidly changing the landscape of these diseases. Traditional approaches such as sequencing methods and arrays have too many limits. These have been overcome by the advent of next generation sequencing (NGS) methods which facilitate and accelerate the analysis of multiple genes and samples. These technologies allow new applications in molecular biology and medicine, for example precise analysis of RNA transcripts for gene expression; profiling of small RNAs, DNA methylation patterns and histone modification analysis; identification of splicing isoforms and of DNA regions that interact with regulatory proteins; pharmacogenomics studies and so on. In this review we describe recent applications of NGS in genomics, transcriptomics and epigenomics for a better comprehension of solid tumor metabolisms.

Original languageEnglish
Pages (from-to)103-117
Number of pages15
JournalCancer Biomarkers
Volume14
Issue number2-3
DOIs
Publication statusPublished - 2014

Fingerprint

Histone Code
RNA
Molecular Medicine
Technology
DNA
DNA Methylation
Genomics
Epigenomics
Molecular Biology
Neoplasms
Protein Isoforms
Gene Expression
Genes
Proteins
Pharmacogenomic Testing

Keywords

  • genomics
  • Next generation sequencing
  • transcriptomics and epigenomics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Genetics

Cite this

The value of new high-throughput technologies for diagnosis and prognosis in solid tumors. / Pinto, Rosamaria; De Summa, Simona; Petriella, Daniela; Tudoran, Oana; Danza, Katia; Tommasi, Stefania.

In: Cancer Biomarkers, Vol. 14, No. 2-3, 2014, p. 103-117.

Research output: Contribution to journalArticle

Pinto, Rosamaria ; De Summa, Simona ; Petriella, Daniela ; Tudoran, Oana ; Danza, Katia ; Tommasi, Stefania. / The value of new high-throughput technologies for diagnosis and prognosis in solid tumors. In: Cancer Biomarkers. 2014 ; Vol. 14, No. 2-3. pp. 103-117.
@article{294e96c2de044a118ccc3e3a052628f5,
title = "The value of new high-throughput technologies for diagnosis and prognosis in solid tumors",
abstract = "Advances in our understanding of the molecular basis of tumors, as well as in the technology of DNA analysis, are rapidly changing the landscape of these diseases. Traditional approaches such as sequencing methods and arrays have too many limits. These have been overcome by the advent of next generation sequencing (NGS) methods which facilitate and accelerate the analysis of multiple genes and samples. These technologies allow new applications in molecular biology and medicine, for example precise analysis of RNA transcripts for gene expression; profiling of small RNAs, DNA methylation patterns and histone modification analysis; identification of splicing isoforms and of DNA regions that interact with regulatory proteins; pharmacogenomics studies and so on. In this review we describe recent applications of NGS in genomics, transcriptomics and epigenomics for a better comprehension of solid tumor metabolisms.",
keywords = "genomics, Next generation sequencing, transcriptomics and epigenomics",
author = "Rosamaria Pinto and {De Summa}, Simona and Daniela Petriella and Oana Tudoran and Katia Danza and Stefania Tommasi",
year = "2014",
doi = "10.3233/CBM-130328",
language = "English",
volume = "14",
pages = "103--117",
journal = "Cancer Biomarkers",
issn = "1574-0153",
publisher = "IOS Press",
number = "2-3",

}

TY - JOUR

T1 - The value of new high-throughput technologies for diagnosis and prognosis in solid tumors

AU - Pinto, Rosamaria

AU - De Summa, Simona

AU - Petriella, Daniela

AU - Tudoran, Oana

AU - Danza, Katia

AU - Tommasi, Stefania

PY - 2014

Y1 - 2014

N2 - Advances in our understanding of the molecular basis of tumors, as well as in the technology of DNA analysis, are rapidly changing the landscape of these diseases. Traditional approaches such as sequencing methods and arrays have too many limits. These have been overcome by the advent of next generation sequencing (NGS) methods which facilitate and accelerate the analysis of multiple genes and samples. These technologies allow new applications in molecular biology and medicine, for example precise analysis of RNA transcripts for gene expression; profiling of small RNAs, DNA methylation patterns and histone modification analysis; identification of splicing isoforms and of DNA regions that interact with regulatory proteins; pharmacogenomics studies and so on. In this review we describe recent applications of NGS in genomics, transcriptomics and epigenomics for a better comprehension of solid tumor metabolisms.

AB - Advances in our understanding of the molecular basis of tumors, as well as in the technology of DNA analysis, are rapidly changing the landscape of these diseases. Traditional approaches such as sequencing methods and arrays have too many limits. These have been overcome by the advent of next generation sequencing (NGS) methods which facilitate and accelerate the analysis of multiple genes and samples. These technologies allow new applications in molecular biology and medicine, for example precise analysis of RNA transcripts for gene expression; profiling of small RNAs, DNA methylation patterns and histone modification analysis; identification of splicing isoforms and of DNA regions that interact with regulatory proteins; pharmacogenomics studies and so on. In this review we describe recent applications of NGS in genomics, transcriptomics and epigenomics for a better comprehension of solid tumor metabolisms.

KW - genomics

KW - Next generation sequencing

KW - transcriptomics and epigenomics

UR - http://www.scopus.com/inward/record.url?scp=84904367055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904367055&partnerID=8YFLogxK

U2 - 10.3233/CBM-130328

DO - 10.3233/CBM-130328

M3 - Article

C2 - 24878811

AN - SCOPUS:84904367055

VL - 14

SP - 103

EP - 117

JO - Cancer Biomarkers

JF - Cancer Biomarkers

SN - 1574-0153

IS - 2-3

ER -